Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction

BACKGROUND: Intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) now improve or stabilize visual acuity in a number of previously untreatable eye diseases, of which the main are age-related macular degeneration, retinal vein occlusion and diabetic macular edema. Most...

Descripción completa

Detalles Bibliográficos
Autores principales: Austeng, Dordi, Morken, Tora Sund, Bolme, Stine, Follestad, Turid, Halsteinli, Vidar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045663/
https://www.ncbi.nlm.nih.gov/pubmed/27716253
http://dx.doi.org/10.1186/s12886-016-0348-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045663/
https://www.ncbi.nlm.nih.gov/pubmed/27716253
http://dx.doi.org/10.1186/s12886-016-0348-4

Ejemplares similares